[The treatment of acquired deficiency of alpha 1-proteinase inhibitor in the early stages of chronic obstructive lung diseases].
A new treatment scheme is proposed with a differential approach to correction of acquired deficiency of proteinase alpha-1 inhibitor. The treatment includes periodically repeated courses of antioxidant agents. In case of failure antioxidant agents are supplemented with courses of substitutive therapy by courses of proteolysis inhibitors up to normalization. Further treatment included repeated courses of antioxidant treatment for a more prolonged remission and prophylaxis of exacerbations.
Samokhina
L M
LM
Gladkov
Iu G
IuG
Efimov
V V
VV
D000328:Adult; D000975:Antioxidants / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D000515:alpha 1-Antitrypsin / Q000032:analysis; D019896:alpha 1-Antitrypsin Deficiency
D000975:Antioxidants; D000515:alpha 1-Antitrypsin
Lechenie priobretennogo defitsita al'fa 1-ingibitora proteinaz na rannikh stadiiakh khronicheskikh obstruktivnykh zabolevaniĭ legkikh.